| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 6, 2023Virtual Press Office and PR Newswire: General Trade show news
Qualys, Inc. (NASDAQ: QLYS), a pioneer and leading provider of disruptive cloud-based IT, security and compliance solutions, today announced that management will participate in a fireside chat and...
-
Nov 6, 2023Virtual Press Office and PR Newswire: General Trade show news
The Luxury Kitchen Appliance Brand Brings its Challenger Mindset & Commitment to Disruptive Progress Back to Dallas BENTON HARBOR, Mich., Nov. 6, 2023 /PRNewswire/ -- JennAir brand returns to...
-
Nov 6, 2023Virtual Press Office and PR Newswire: General Trade show news
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Dean Schorno, the company's chief financial officer, will present a company overview at the Jefferies 2023 London Healthcare...
-
Nov 6, 2023RSNA Press Room: Exhibitor and Show News and Content
Two oral presentations and five ePosters accepted by the RSNA: presenting AI advancements for chest radiograph reporting efficiency and breast cancer risk assessment SEOUL, South Korea, Nov. 6,...
-
Nov 6, 2023Virtual Press Office and PR Newswire: General Trade show news
Actimab-A can target CD33 positive immune suppressing myeloid derived suppressor cells and restore T cell proliferation and effector response Solid tumor MDSC infiltration and uptake of Actimab-A...
